• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RUNX1 和 RUNX1-ETO:在造血和白血病发生中的作用。

RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.

机构信息

Moores Cancer Center, Department of Pathology and Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA.

出版信息

Front Biosci (Landmark Ed). 2012 Jan 1;17(3):1120-39. doi: 10.2741/3977.

DOI:10.2741/3977
PMID:22201794
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3433167/
Abstract

RUNX1 is a transcription factor that regulates critical processes in many aspects of hematopoiesis. RUNX1 is also integral in defining the definitive hematopoietic stem cell. In addition, many hematological diseases like myelodysplastic syndrome and myeloproliferative neoplasms have been associated with mutations in RUNX1. Located on chromosomal 21, the RUNX1 gene is involved in many forms of chromosomal translocations in leukemia. t(8;21) is one of the most common chromosomal translocations found in acute myeloid leukemia (AML), where it results in a fusion protein between RUNX1 and ETO. The RUNX1-ETO fusion protein is found in approximately 12% of all AML patients. In this review, we detail the structural features, functions, and models used to study both RUNX1 and RUNX1-ETO in hematopoiesis over the past two decades.

摘要

RUNX1 是一种转录因子,可调节造血过程多方面的关键过程。RUNX1 对于定义确定性造血干细胞也很重要。此外,许多血液疾病,如骨髓增生异常综合征和骨髓增殖性肿瘤,都与 RUNX1 突变有关。RUNX1 基因位于染色体 21 上,参与白血病中多种形式的染色体易位。t(8;21)是急性髓系白血病 (AML)中最常见的染色体易位之一,它导致 RUNX1 和 ETO 之间形成融合蛋白。RUNX1-ETO 融合蛋白约存在于所有 AML 患者的 12%中。在这篇综述中,我们详细介绍了过去二十年来用于研究造血过程中的 RUNX1 和 RUNX1-ETO 的结构特征、功能和模型。

相似文献

1
RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.RUNX1 和 RUNX1-ETO:在造血和白血病发生中的作用。
Front Biosci (Landmark Ed). 2012 Jan 1;17(3):1120-39. doi: 10.2741/3977.
2
Runx1/AML1 in normal and abnormal hematopoiesis.正常及异常造血过程中的Runx1/AML1
Int J Hematol. 2005 Jul;82(1):1-8. doi: 10.1532/IJH97.05075.
3
Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis.Runx1对斑马鱼的血液和血管发育是必需的,并且人类RUNX1-CBF2T1转基因的表达推进了白血病发生研究的模型。
Development. 2002 Apr;129(8):2015-30. doi: 10.1242/dev.129.8.2015.
4
Runx1/AML-1 ranks as a master regulator of adult hematopoiesis.Runx1/AML-1被视为成人造血作用的主要调节因子。
Cell Cycle. 2004 Jun;3(6):722-4. Epub 2004 Jun 28.
5
Core binding factor genes and human leukemia.核心结合因子基因与人类白血病
Haematologica. 2002 Dec;87(12):1307-23.
6
Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.t(8;21)AML 细胞中 RUNX1/ETO 的耗竭导致染色质结构和转录因子结合的全基因组变化。
Leukemia. 2012 Aug;26(8):1829-41. doi: 10.1038/leu.2012.49. Epub 2012 Feb 20.
7
Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.急性白血病发病机制中的白血病前期RUNX1和CBFβ突变
Cancer Treat Res. 2010;145:127-47. doi: 10.1007/978-0-387-69259-3_8.
8
Cooperation between RUNX1-ETO9a and novel transcriptional partner KLF6 in upregulation of Alox5 in acute myeloid leukemia.RUNX1-ETO9a 与新型转录伙伴 KLF6 在急性髓系白血病中协同上调 Alox5 的表达。
PLoS Genet. 2013;9(10):e1003765. doi: 10.1371/journal.pgen.1003765. Epub 2013 Oct 10.
9
The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.致白血病的t(8;21)融合蛋白AML1-ETO控制核糖体RNA基因,并与有丝分裂染色体上的核仁组织区相关联。
J Cell Sci. 2008 Dec 1;121(Pt 23):3981-90. doi: 10.1242/jcs.033431. Epub 2008 Nov 11.
10
Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.胚胎干细胞造血分化过程中AML/Runx和ETO/MTG家族成员的表达
Exp Hematol. 2007 Jun;35(6):978-88. doi: 10.1016/j.exphem.2007.03.002.

引用本文的文献

1
Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AML.失调的先天免疫信号传导与RUNX1突变协同作用,将类似骨髓增生异常综合征的疾病转化为急性髓系白血病。
iScience. 2024 Apr 24;27(6):109809. doi: 10.1016/j.isci.2024.109809. eCollection 2024 Jun 21.
2
hsa‑miR‑455‑3P as a predictive biomarker of anemia in patients with non‑small cell lung cancer treated with carboplatin plus paclitaxel.hsa-miR-455-3P作为接受卡铂联合紫杉醇治疗的非小细胞肺癌患者贫血的预测生物标志物。
Oncol Lett. 2024 Mar 21;27(5):219. doi: 10.3892/ol.2024.14350. eCollection 2024 May.
3
Deciphering Acute Myeloid Leukemia Associated Transcription Factors in Human Primary CD34+ Hematopoietic Stem/Progenitor Cells.解析人类原代 CD34+ 造血干/祖细胞中与急性髓系白血病相关的转录因子。
Cells. 2023 Dec 29;13(1):78. doi: 10.3390/cells13010078.
4
The effects of thioredoxin peroxidase from Cysticercus cellulosae excretory-secretory antigens on TGF-β signaling pathway and Th17 cells differentiation in Jurkat cells by transcriptomics.旋毛形线虫细胞外排泄分泌抗原中的硫氧还蛋白过氧化物酶通过转录组学对 Jurkat 细胞中 TGF-β 信号通路和 Th17 细胞分化的影响。
Parasitol Res. 2023 Dec 14;123(1):50. doi: 10.1007/s00436-023-08075-z.
5
Hepatic Runx1t1 improves body fat index after endurance exercise in obese mice.肝组织 Runx1t1 在肥胖小鼠耐力运动后改善体脂指数。
Sci Rep. 2023 Nov 8;13(1):19427. doi: 10.1038/s41598-023-46302-w.
6
Germline and somatic drivers in inherited hematologic malignancies.遗传性血液系统恶性肿瘤中的种系和体细胞驱动因素。
Front Oncol. 2023 Oct 13;13:1205855. doi: 10.3389/fonc.2023.1205855. eCollection 2023.
7
Protein-Nanocaged Selenium Induces t(8;21) Leukemia Cell Differentiation via Epigenetic Regulation.蛋白纳米笼硒通过表观遗传调控诱导 t(8;21)白血病细胞分化。
Adv Sci (Weinh). 2023 Dec;10(35):e2300698. doi: 10.1002/advs.202300698. Epub 2023 Oct 27.
8
Novel Variation in B-cell Acute Lymphoblastic Leukemia.B细胞急性淋巴细胞白血病的新型变异
Mediterr J Hematol Infect Dis. 2023 Jul 1;15(1):e2023036. doi: 10.4084/MJHID.2023.036. eCollection 2023.
9
The RUNX Family of Proteins, DNA Repair, and Cancer.RUNX 蛋白家族、DNA 修复与癌症
Cells. 2023 Apr 7;12(8):1106. doi: 10.3390/cells12081106.
10
Deregulated Gene Expression Profiles and Regulatory Networks in Adult and Pediatric RUNX1/RUNX1T1-Positive AML Patients.成人和儿童RUNX1/RUNX1T1阳性急性髓系白血病患者的基因表达谱失调与调控网络
Cancers (Basel). 2023 Mar 16;15(6):1795. doi: 10.3390/cancers15061795.

本文引用的文献

1
Phosphorylation of RUNX1 by cyclin-dependent kinase reduces direct interaction with HDAC1 and HDAC3.RUNX1 的磷酸化由细胞周期蛋白依赖性激酶介导,从而减少了与 HDAC1 和 HDAC3 的直接相互作用。
J Biol Chem. 2011 Jan 7;286(1):208-15. doi: 10.1074/jbc.M110.149013. Epub 2010 Nov 8.
2
Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators.血液干/祖细胞中的组合转录调控:十个主要转录调控因子的全基因组分析。
Cell Stem Cell. 2010 Oct 8;7(4):532-44. doi: 10.1016/j.stem.2010.07.016.
3
Identification and molecular characterization of a novel 3′ mutation in RUNX1 in a family with familial platelet disorder.一个患有家族性血小板疾病的家族中RUNX1基因新的3′突变的鉴定与分子特征分析
Leuk Lymphoma. 2010 Oct;51(10):1931-5. doi: 10.3109/10428194.2010.503821.
4
A Runx1 intronic enhancer marks hemogenic endothelial cells and hematopoietic stem cells.Runx1 内含子增强子标记造血内皮细胞和造血干细胞。
Stem Cells. 2010 Oct;28(10):1869-81. doi: 10.1002/stem.507.
5
Structure of the AML1-ETO NHR3-PKA(RIIα) complex and its contribution to AML1-ETO activity.AML1-ETO 复合物的 NHR3-PKA(RIIα)结构及其对 AML1-ETO 活性的贡献。
J Mol Biol. 2010 Sep 24;402(3):560-77. doi: 10.1016/j.jmb.2010.08.007. Epub 2010 Aug 11.
6
Genetic manipulation of AML1-ETO-induced expansion of hematopoietic precursors in a Drosophila model.利用果蝇模型对 AML1-ETO 诱导的造血前体细胞扩增进行遗传操作。
Blood. 2010 Nov 25;116(22):4612-20. doi: 10.1182/blood-2010-03-276998. Epub 2010 Aug 5.
7
AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2.AML1在骨髓增殖性肿瘤患者中过表达,并介导NF-E2的不依赖JAK2V617F的过表达。
Blood. 2010 Jul 15;116(2):254-66. doi: 10.1182/blood-2009-11-254664. Epub 2010 Mar 25.
8
Nonredundant roles for Runx1 alternative promoters reflect their activity at discrete stages of developmental hematopoiesis.Runx1 替代启动子的非冗余作用反映了它们在发育性造血的不同阶段的活性。
Blood. 2010 Apr 15;115(15):3042-50. doi: 10.1182/blood-2009-08-238626. Epub 2010 Feb 4.
9
NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells.在AML1-ETO阳性髓系白血病细胞中,ETO的NHR4结构域突变可能非常罕见。
Leukemia. 2010 Apr;24(4):860-1. doi: 10.1038/leu.2009.291. Epub 2010 Jan 21.
10
DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.DNA 甲基化特征可识别急性髓细胞白血病中的生物学亚型。
Cancer Cell. 2010 Jan 19;17(1):13-27. doi: 10.1016/j.ccr.2009.11.020. Epub 2010 Jan 7.